Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

• Autores principales: Felisiak-Golabek Anna (Autor), Rembiszewska Alina (Autor), Rzepecka Iwona K (Autor), Szafron Lukasz (Autor), Madry Radoslaw (Autor), Murawska Magdalena (Autor), Napiorkowski Tomasz (Autor), Sobiczewski Piotr (Autor), Osuch Beata (Autor), Kupryjanczyk Jolanta (Autor)
• Formato: Libro
• Publicado: BMC, 2011-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in...